High-Performance Bioprocessing Products
At enGenes, we create high-performance tools to transform bioprocessing — from upstream fermentation to downstream purification.
Our product portfolio includes a cost-effective endonuclease and a versatile range of affinity ligands, all produced with our proprietary -eXpress, -eXtra, and -eXcite platforms to deliver reliability, scalability, and efficiency.
eXrase
eXrase™ – Smart DNA Digestion, Real Cost Savings
eXrase is a next-generation recombinant endonuclease that delivers powerful DNA/RNA digestion at a fraction of the cost of traditional market enzymes — without compromising performance.
Key Benefits:
-
Up to 30× cost savings vs Benzonase® and similar nucleases
-
Rapid reduction of lysate viscosity, enabling smoother downstream handling
-
Improved chromatographic flow rates and higher protein yields
-
Manufactured with -eXpress and -eXtra for consistent, scalable production
Applications:
-
Viscosity control during cell harvest and clarification
-
Enhanced filtration and purification throughput
-
Increased recovery and purity of target proteins
Available in research-grade, technical-grade, and bulk formats.
Affinity Ligands
Affinity Ligands – High-Performance Capture, Without the High Cost
Our affinity ligands are designed to support efficient and selective purification of biotherapeutics, from discovery to large-scale manufacturing — without the price tag of traditional solutions.
Product Portfolio:
-
Wild-Type Protein A
-
Protein A with C-terminal Cysteine (for site-specific, directional immobilization)
-
Synthetic Tetrameric and Hexameric Ligands
-
Custom Ligands tailored to specific targets or processes
Manufactured using -eXpress and -eXtra, with optional -eXcite for full end-to-end continuous production.
Why It Matters:
-
Optimized for high-efficiency capture of antibodies and proteins
-
Offers exceptional binding stability and low leaching risk
-
Enables site-specific, directional immobilization for enhanced process control
-
Supports cost-effective custom resin development using alternative Protein A sources — unlocking more affordable, tailored bioprocessing solutions
